These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
600 related items for PubMed ID: 11169513
1. Nuclear cytometric changes in breast carcinogenesis. Mommers EC, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ. J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513 [Abstract] [Full Text] [Related]
2. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade. Mommers EC, Leonhart AM, Falix F, Michalides R, Meijer CJ, Baak JP, Diest PJ. J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365 [Abstract] [Full Text] [Related]
3. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer. Mariuzzi L, Mombello A, Rucco V, Morelli L, Zamò A, Thompson D, Vaught L, Bartels HG, Mariuzzi G, Bartels PH. Adv Clin Path; 2000 Apr; 4(2):87-97. PubMed ID: 11080789 [Abstract] [Full Text] [Related]
9. Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast. Susnik B, Worth A, Palcic B, Poulin N, LeRiche J. Anal Cell Pathol; 1995 Jan; 8(1):39-52. PubMed ID: 7734410 [Abstract] [Full Text] [Related]
10. Breast carcinogenesis. Transition from hyperplasia to invasive lesions. Meteoglu I, Dikicioglu E, Erkus M, Culhaci N, Kacar F, Ozkara E, Uyar M. Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768 [Abstract] [Full Text] [Related]
11. Quantitative study of breast cancer progression: different pathways for various in situ cancers. Mariuzzi L, Mombello A, Granchelli G, Rucco V, Tarocco E, Frank D, Davis J, Thompson D, Bartels H, Mariuzzi GM, Bartels PH. Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837 [Abstract] [Full Text] [Related]
12. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H. Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540 [Abstract] [Full Text] [Related]
14. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Wärnberg F, Nordgren H, Bergkvist L, Holmberg L. Br J Cancer; 2001 Sep 14; 85(6):869-74. PubMed ID: 11556839 [Abstract] [Full Text] [Related]